Bicycle Therapeutics

BCYC | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.63

-$0.02 (-0.55%)

At close: Sep 21, 2026, 4:00 PM ET

$3.63

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.55%

(1D)

Rating

Updated: Aug 29, 2026

27.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $251.9M

1D Range

3.63 3.69

52W Range

3.61 9.16

Valuation (TTM)

PE -1.33

PB 0.49

EV/EBITDA 1.33

Valuation (NTM)

Forward PE N/A

Forward PEG 0.30

Price Target $12

Cash Flow

FCF Yield -81.6%

SBC Adj. FCF Yield -79.3%

SBC Impact -2.8%

Margins

Gross Margin 100.0%

Operating Margin -343.7%

FCF Margin -335.9%

Growth (CAGR)

Revenue 3Y | 5Y 39.6% | 40.2%

Dil EPS 3Y | 5Y 16.1% | 5.1%

FCF 3Y | 5Y -10.5% | -33.5%

Returns

ROA -31.4%

ROE -33.2%

ROIC -37.6%

Financial Health

Net Cash

$510.05M

Current Ratio 12.08

Interest Coverage -1,089.93

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently...

Sector Healthcare

Industry Biotechnology

Employees 288

IPO Date May 22, 2019

Website www.bicycletherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Oct 29, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$12

Upside

+230.58%

Buy (3)

Hold (1)

Sell (0)

Analyst Details ➞